Unilife (NSDQ:UNIS) shares are up more than 24% this week on a supply deal for its wearable injectors it inked with MedImmune, the biologics division of pharma giant AstraZeneca (NYSE:AZN).
Unilife Corp.
Forbes articles were a ‘vindictive attack on me personally,’ says Unilife CEO
NuVasive takes a shellacking on lowered guidance | Wall Street Beat
NuVasive Inc. (NSDQ:NUVA) shares are down more than 30% today after the medical device company said yesterday that its 3rd-quarter results are likely to be substantially lower than predicted.
San Diego-based NuVasive, which makes spinal surgery implants, said 3rd-quarter sales will be about $147 million, 4.8% below the roughly $154.4 million the company expected to post.
Unilife preps $19M offering | Funding Roundup
Unilife ditches employment agreements for most of its C-suite | Personnel Moves
Globus Medical files for IPO | Wall Street Beat
Globus Medical filed for an initial public offering yesterday, saying it’s planning a reverse split of its existing stock just before the IPO launches.
The Audubon, Pa.-based orthopedic device maker, which ran afoul of the FDA last month, said it hopes to trade under the "GMED" ticker on the New York Stock Exchange.
Insulet gains after paring Q4, 2011 losses | Earnings Roundup
Wall Street investors drove Insulet (NSDQ:PODD) shares up nearly 4% today ahead of the insulin management company’s 4th-quarter and full-year earnings statement.
Bedford, Mass.-based Insulet posted losses of $14.3 million, or 30 cents per share, on sales of $47.2 million for the 3 months ended Dec. 31, 2011, adding 70% to the top line and shaving 31.3 percent off of its losses, compared with the same period in 2010.
Mako Surgical boosts Q3 sales, losses still widen | Earnings Roundup
Shares of Mako Surgical (NSDQ:MAKO) are down 6.6 percent since the robotic surgery firm reported wider third-quarter losses, despite a nearly 67 percent increase in sales.
Mako reported losses of $9.7 million, or 24 cents per share, on sales of $20.0 million during the three months ended Sept. 30.
Maquet inks GPO deal with Premier
Getinge Group (STO:GETI B) subsidiary Maquet Cardiovascular inked a three-year contract with U.S. group purchasing organization Premier Healthcare Alliance for its intra-aortic balloon pumps.
The contract includes Maquet’s CS300 product line, as well as its Mega, Sensation, and Linear catheters used to treat acute heart failure, irregular heart rhythms and other cardiac problems.
Maquet’s Sensation Plus aortic balloon catheter won FDA approval and CE Mark clearance late last month.
Unilife wins supply contract with Premier health care alliance
Unilife Corp. (NSDQ:UNIS) announced a two-year deal with Premiere Inc. to supply the U.S. group purchasing organization with its Unitract 1mL safety syringes.
The contract calls for York, Pa.-based Unilife to help stock Premiere’s more than 76,000 health care sites nationwide.
Unilife Wins Supply Contract with Nation’s Largest Healthcare Alliance
Premier Selects Unitract 1mL safety syringes for Two-Year Contract
YORK, P.A., Oct. 5, 2011 /PRNewswire/ — Unilife Corporation (“Unilife” or the “Company”) (NASDAQ: UNIS; ASX: UNS) today announced it has been awarded a two-year contract by Premier Purchasing Partners, L.P., the group purchasing enterprise of the Premier healthcare alliance, for the supply of its Unitract® 1mL safety syringes.
Premier, Inc. is the nation’s largest healthcare alliance, helping to improve performance and providing group contracting to more than 2,500 U.S. hospitals and over 76,000 healthcare sites nationwide.